Novo will add Akero’s efruxifermin to its MASH portfolio, which includes Wegovy after the GLP-1 gained an FDA nod in the ...

New analysis from Jefferies shows that rare disease and cancer drugs granted the status are especially likely to be approved.

Privately-held Ferring Pharmaceuticals will part ways with up to 500 employees across its global operations in a bid to ...

The CDC’s Advisory Committee on Immunization Practices was scheduled to convene Oct. 22 to 23, but this meeting has been ...

Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.

A new survey from CRB showed that most manufacturing initiatives in the U.S. made in response to tariffs are coming from Big ...

Takeda wanted to create something new in the cell therapy world by combining the technology with T cell engagers. A series of ...

Six months after his controversial departure from the top spot at the FDA’s biologics division, Peter Marks has landed at Eli ...

The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo ...

Following up on previous, dimly received issuances, a new set of ideas published by the FDA to streamline regulatory pathways ...

The U.S. government remains shut down, with the FDA closed for new drug applications until further notice; cell and gene ...

Sanofi’s Orano Med-partnered radioligand therapy AlphaMedix achieved all primary efficacy endpoints, which included a measure of overall response rate, in the mid-stage ALPHAMEDIX-02 study.